The cancer vaccines assist in the treatment of the existing cancer or prevent the development of cancer; the former are known as therapeutic cancer vaccines. Several vaccines are "autologous," as they are prepared from the samples obtained from cancer patients, and such vaccines are unique to that patient. Cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. Cervarix, Gardasil, Gardasil-9, and Hepatitis B (HBV) vaccine (HEPLISAV-B) are preventive cancer vaccines, whereas, Sipuleucel-T (Provenge) are therapeutic cancer vaccines. The global cancer vaccines market is driven by factors such as increasing R&D expenditures by pharmaceutical companies, and rising government support for research activities and clinical trials. However, the high cost of drug development hinders the market growth. However, emerging markets are creating growth opportunities for the market players.

Top Companies Analysis-

CSL Limited
ADURO BIOTECH INC.
Astellas Pharma Inc.
Merck & Co., Inc.
Sanofi
Bristol-Myers Squibb Company
Glaxosmithkline Plc.
Dendreon
ASTRAZENECA PLC.
OSE Immunotherapeutics

Type-Based Insights
The cancer vaccines market, by type, is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR in the market during the forecast period.

Indication-Based Insights
The cancer vaccines market, by indication, is segmented into cervical cancer, prostate cancer, and other indications. The cervical cancer segment held the largest share of the market in 2019, and the market for this segment is anticipated to witness the highest CAGR during the forecast period.
End User-Based Insights
The cancer vaccines market, by end user, is segmented into pediatrics and adults. The pediatrics segment held a larger share of the market in 2019, and the same segment is anticipated to register a higher CAGR of 17.4% during the forecast period.

Leading Industry players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position are explained to help make a well informed decision. Competitive landscape of Cancer Vaccines Industry is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

About Us:                    

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, and Chemicals

Contact Us:                        

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876